Research  >  Research centres  >  Harquail Centre for Neuromodulation

Visitors are not permitted at Sunnybrook during the COVID-19 pandemic

Sunnybrook is taking extra precautions to ensure the safety of our patients and staff during the COVID-19 pandemic. This means changes to our visitor guidelines and screening for symptoms at the door.

» Learn more about this and other COVID-19 information

About the Harquail Centre for Neuromodulation

The Harquail Centre for Neuromodulation at Sunnybrook is the world’s first to offer a complete range of neuromodulation strategies in one state-of-the-art facility.

Our internationally recognized researchers and scientists are investigating minimal- and non-invasive technology to target pathways in the brain that are at the root of the most common and challenging brain disorders including: Alzheimer’s disease, Parkinson’s Disease, ALS, essential tremor, major depression, OCD, and others.

The experts at The Harquail Centre are committed to investigating and developing novel treatments that are individualized and tailored to our patients’ needs.

What is neuromodulation?

Learn about this rapidly evolving field and its applications...

Learn more >